Back to Authors

Edeani, Amaka

https://orcid.org/0000-0002-4628-2993

Mayo Clinic

National Institutes of Health

Citations 1

Paraprotein–Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance
Rosner, Mitchell H. , Edeani, Amaka , Yanagita, Motoko , Forum, for the American Society of Nephrology Onco-Nephrology, Rosner, Mitchell H. , Glezerman, Ilya G , Leung, Nelson , Forum, for the American Society of Nephrology Onco-Nephrology

Clinical Journal of the American Society of Nephrology | August 15, 2016 | Volume: 11 | Issue: 12 | Pages: 2280-2287

10.2215/cjn.02920316 Get It

Paraprotein–related kidney disease represents a complex group of diseases caused by an abnormal paraprotein secreted by a clone of B cells. The disease manifestations range from tubulopathies, such as the Fanconi syndrome, to a spectrum of glomerular diseases that can present with varying degrees of proteinuria and renal dysfunction. Diagnosis of these diseases can be challenging because of the wide range of manifestations as well as the relatively common finding of a serum paraprotein, especially in elderly patients. Thus, renal biopsy along with detailed hematologic workup is essential to link the presence of the paraprotein to the associated renal disease. Recent advances in treatment with more effective and targeted chemotherapies, as well as stem cell transplantation, have improved the renal and overall prognosis for many of these disorders.